Filtered By:
Cancer: Anal Cancer
Vaccination: Cervical Cancer Vaccine
This page shows you your search results in order of date.
Order by Relevance | Date
Total 155 results found since Jan 2013.
Applying the COM-B behaviour model to understand factors which impact school immunisation nurses' attitudes towards designing and delivering a HPV educational intervention in post-primary schools for 15-17 year old students in Northern Ireland, UK
CONCLUSION: IMNs feel that they are the most appropriate professionals to design/deliver HPV education for 15-17 year old students. National policy change, based on collaboration between the Public Health Agency and Education Authority, is a key factor in facilitating IMNs to implement this school-based HPV education intervention.PMID:37543445 | DOI:10.1016/j.vaccine.2023.07.066
Source: Vaccine - August 5, 2023 Category: Allergy & Immunology Authors: Terri Flood Marian McLaughlin Ciara M Hughes Iseult M Wilson Source Type: research
Therapeutic Vaccination against Human Papillomavirus Type 16 for the Treatment of Anal Intraepithelial Neoplasia in HIV+ Men
CONCLUSIONS: The highest dose level is safe, immunogenic and associated with clinical responses to HPV16-induced lesions. However, as the majority of HGAIN is caused by the other HPV types, further studies should aim at pan-HPV vaccination to prevent or treat HGAIN.PMID:37540563 | DOI:10.1158/1078-0432.CCR-22-3361
Source: Clinical Cancer Research - August 4, 2023 Category: Cancer & Oncology Authors: Karien C M Gosens Sjoerd H van der Burg Marij J P Welters Sanne Boekestijn Nikki M Loof Wim G V Quint Carel J M van Noesel Allard C van der Wal Olivier Richel Wilhelmus J T A Krebber Cornelis J M Melief Henry J C de Vries Jan M Prins Source Type: research
Advances in HPV-associated tumor management: Therapeutic strategies and emerging insights
J Med Virol. 2023 Jul;95(7):e28950. doi: 10.1002/jmv.28950.ABSTRACTWith the rapid increase in the incidence of cervical cancer, anal cancer and other cancers, human papillomavirus (HPV) infection has become a growing concern. Persistent infection with high-risk HPV is a major cause of malignant tumors. In addition, microbiota and viruses such as human immunodeficiency virus, herpes simplex virus, and Epstein-Barr virus are closely associated with HPV infection. The limited effectiveness of existing treatments for HPV-associated tumors and the high rates of recurrence and metastasis in patients create an urgent need for nov...
Source: Herpes - July 19, 2023 Category: Infectious Diseases Authors: Xiangjin Gong Hao Chi Zhijia Xia Guanhu Yang Gang Tian Source Type: research
Prevalence and distribution of high-risk Human Papillomavirus in Western T ürkiye between 2019 and 2022
This study indicates the need for higher coverage of HPV vaccination in Western Türkiye.PMID:37347660 | DOI:10.1556/030.2023.02066
Source: Acta Microbiologica et Immunologica Hungarica - June 22, 2023 Category: Microbiology Authors: G ülfem Terek Ece Do ğukan Pira G ökçe Lara Bodur Source Type: research
Role of Low-Risk HPV PCR Monoinfection in Screening for HSIL and Anal Cancer in Men Who Have Sex with Men Living with HIV
Int J Mol Sci. 2023 Mar 15;24(6):5642. doi: 10.3390/ijms24065642.ABSTRACTTo determine the value of low-risk human papillomavirus (HPV) PCR to screen for "high-grade anal squamous intraepithelial lesion and anal cancer" (HSIL-plus), rate of patients with low-grade anal squamous intraepithelial lesion (LSIL) progressing to HSIL-plus, and progression-related factors. Prospective, longitudinal study of consecutive MSM-LHIV attended between May 2010 and December 2021 and followed for 43 months (IQR: 12-76). HIV-related variables were gathered at baseline, performing anal cytology for HPV detection/genotyping, thin-layer cytolog...
Source: Anal Sci - March 29, 2023 Category: Chemistry Authors: Carmen Mar ía García-Martínez Inmaculada Calle-G ómez Javier L ópez-Hidalgo Patricia G ómez-Ronquillo Mohamed Omar-Mohamed Balgahata Carmen Hidalgo-Tenorio Source Type: research
